Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma

Renal cell carcinoma (RCC) is a fatal disease when advanced. While immunotherapy and tyrosine kinase inhibitor-based combinations are associated with improved survival, the majority of patients eventually succumb to the disease. Through a comprehensive pan-cancer, pan-kinome analysis of the Cancer G...

Descripción completa

Detalles Bibliográficos
Autores principales: Essegian, Derek J., Chavez, Valery, Bustamante, Floritza, Schürer, Stephan C., Merchan, Jaime R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713373/
https://www.ncbi.nlm.nih.gov/pubmed/36465101
http://dx.doi.org/10.1016/j.isci.2022.105621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713373/
https://www.ncbi.nlm.nih.gov/pubmed/36465101
http://dx.doi.org/10.1016/j.isci.2022.105621

Ejemplares similares